Synaptica
Intelligent Medical Diagnostics
The fusion of medical intelligence. Where pathology, radiology, genomics, and proteomics converge to deliver diagnostic certainty for national healthcare systems.
Cross-Attention Transformer Architecture · Multi-Modal AI Integration
National Diagnostic Infrastructure
Synaptica transforms fragmented diagnostic workflows into a unified national capability. Not software — critical healthcare infrastructure.
Whole-Slide Digital Pathology
AI-powered analysis of 40GB multi-resolution tissue samples with sub-cellular precision heatmaps.
Radiology Integration
Volumetric CT/MRI/PET analysis with 3D feature extraction and spatial correlation to tissue findings.
Genomic Triage
Automated variant calling, mutation profiling, and treatment pathway matching against national formularies.
Proteomic Profiling
Mass-spectrometry protein expression analysis confirms which mutations are functionally active — resolving genomic ambiguity and lifting the Diagnostic Certainty Index.
Dynamic Load-Balancing
Intelligent case routing to specialists based on complexity, ensuring optimal workforce utilization.
National Dashboard
Real-time geo-mapped cancer surveillance with automated cluster detection and epidemiological alerts.
Offline-First Architecture
Edge-deployed AI operates without internet. Zero downtime, zero data loss when connectivity returns.
Cross-Attention Transformer Engine
The world's first multi-modal diagnostic fusion engine purpose-built for national-scale cancer diagnostics.
Pathology
Radiology
Genomics
ProteomicsData Normalization
Microservices pipeline converts pathology (SVS/NDPI), radiology (DICOM), genomics (VCF/FASTQ), and proteomics (mzML/mass-spec) into unified tensor representations.
Cross-Attention Fusion
Custom Transformer architecture enables each modality to 'attend' to others. Genomic signals guide pathology re-examination; proteomic expression confirms which mutations are functionally active; radiology context enriches tissue analysis.
Conflict Resolution
Bayesian Probability Network assigns dynamic trust scores. When modalities disagree, automatic escalation generates MDT summaries for human review.
Explainable Output
SHAP-based explainability shows contributing factors per modality. Clinicians audit AI reasoning in seconds, not hours.
Transforming Healthcare in Underserved Regions
Delivering world-class diagnostic capability to the communities that need it most. Infrastructure built for resilience, not convenience.
Challenge
Fragmented island health systems with critical pathologist shortages. Average 1 pathologist per 500,000 population.
Synaptica Solution
Centralized hub-and-spoke model. Edge AI at rural clinics, specialist review at regional centres.
Challenge
Continent-wide diagnostic desert. Less than 1% of pathology capacity needed for cancer burden.
Synaptica Solution
Federated learning across national networks. Platform improves annually on local population demographics.
Challenge
Extreme geographic isolation. Samples currently shipped overseas with 6-8 week turnaround.
Synaptica Solution
Offline-first deployment. Full diagnostic AI capability with zero internet dependency.
Cancer Diagnostics & Beyond
Starting with the highest-impact clinical need and expanding to address the full spectrum of diagnostic pathology.
Solid Tumour Diagnosis
Breast, lung, colorectal, cervical, and prostate cancers. Automated Gleason grading, mitotic counting, and PD-L1 expression analysis.
Haematological Malignancies
Leukaemia subtyping, lymphoma classification. Automated peripheral blood smear analysis and bone marrow assessment.
Precision Therapy Matching
EGFR, KRAS, BRAF, HER2 mutation prediction from digital slides. Cross-referenced with national formularies for treatment recommendations.
Pre-Cancer Screening
Automated cervical cytology (Pap smear), Barrett's oesophagus surveillance. Population-scale screening with >99.9% NPV.
Cardiovascular Pathology
Cardiac biopsy analysis for transplant rejection grading. Integration with echocardiography and cardiac MRI data streams.
Infectious Disease
TB detection from tissue samples, parasitology automation. Critical for tropical disease burden in target markets.
Strategic Partner in National Cancer Control
Synaptica is not a software purchase. It is a national capacity investment with guaranteed outcomes and shared risk.
Diagnostic Certainty Index (DCI)
Proprietary 0–100 metric. Unimodal pathology: DCI 70. Add genomics: DCI 88. Full multi-modal: DCI 96. Each DCI point = 8% fewer unnecessary second biopsies.
Performance-Linked Pricing
Fixed annual "National Capacity-as-a-Service" subscription. If agreed KPIs are not met, automatic 20% rebate. We share your risk.
Zero-Config Deployment
HL7-FHIR compliant APIs plug into any existing HIS/LIS in under 48 hours. Your workflow stays — Synaptica adapts.
Sovereign Data Control
All patient data remains within national borders. Federated learning improves the model without exporting sensitive information.
Deployment Tiers
Pathology-only AI for rural clinics and district hospitals
- Digital pathology AI
- Automated triage
- Basic reporting
Multi-modal integration for regional referral centres
- + Genomic triage
- + Workforce load-balancing
- + Structured reporting
Full enterprise deployment for entire national health system
- + National dashboard
- + Population surveillance
- + Federated learning
Measurable Outcomes
Evidence-based projections for national health system transformation.
Diagnostic Accuracy by Modality
Sensitivity across cancer subtypes
Diagnostic Certainty Index (DCI)
Impact of multi-modal integration
Powered by Ancestra Health
Synaptica is developed and deployed by Ancestra Health, a division of the Ancestra Group.
"Built on Integrity, Driven by Vision"
Ancestra Health brings together world-class engineering, clinical expertise, and deep understanding of emerging-market healthcare systems to deliver diagnostic capability where it is needed most.
Our approach is rooted in the belief that diagnostic certainty should not be determined by geography or economic status. Every patient deserves the same standard of diagnostic accuracy, whether in Kingston, Nairobi, or Suva.
Request a Strategic Briefing
Connect with our team to discuss how Synaptica can transform your national diagnostic capability.
For Government Officials
We offer confidential executive briefings tailored to your national health strategy. Our team will prepare a customized assessment of your diagnostic infrastructure gaps and a roadmap for implementation.
All inquiries are treated with the highest level of confidentiality. Your data is stored securely and will only be used to respond to your request.